# SINOMED acquires 72.73% stake in eLum Technologies for $20.73M

SINOMED announced the acquisition of a 72.73% equity interest in U.S.-based eLum Technologies, Inc. for USD 20.73 million, marking its entry into the neurointerventional device market. The transaction gives SINOMED control of approximately 90.91% of eLum.

- Type: Acquisition
- Announced: 2023-09-07
- Where: Delaware, United States
- Value: $20.7M
- Status: announced
- Products: neurointerventional medical devices, distal embolic protection system, flow diverter
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [SINOMED](https://endata.com/companies/72471.md) (acquirer)
- [eLum Technologies](https://endata.com/companies/72472.md) (target)

## Sources

- [sinomed.com](https://www.sinomed.com/sinomed-strengthens-neurointerventional-platform-with-strategic-acquisition-of-72-73-stake-in-u-s-elum-technologies/), 2023-09-07: "SINOMED today announced the acquisition of 72.73% equity interest in U.S.-based eLum Technologies, Inc. for USD 20.73 million (approximately RMB 152 million) in self-raised funds."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.